Single-lung retransplantation for late graft failure.
|
|
- Brooke Bradley
- 5 years ago
- Views:
Transcription
1 Eur Resplr J, 1993, 6, Printed in UK all rights reserved Copyright ERS Journals Ltd 1993 European Respiratory Journal ISSN Single-lung retransplantation for late graft failure M. Foumier*, C. Sleiman*, H. Mal*, 0. Groussard+, J-L. Mollo*, J-P. Duchatelle++, B. Andreassian++, A. Pariente* Single-lung retransplantation for late graft failure. M. Foumier, C. Sleiman, H. Mal, 0. Groussard, J-L Mollo, J-P. Duchatelle, B. Andreassian, R. Pariente. ERS Journals Lld ABSTRACT: In lung or heart-lung re<:ipients, an irreversible graft-failure may develop in connection with chronic rejection, infection or bronchial complications. A limited number of transplant-re<:ipients have undergone a retraosplantation procedure in several centres. First results are discouraging, especially in the case of early retraosplantation. We decided, 3 yrs ago, to evaluate the feasibility and benefits of single-lung retransplantation in lung-transplant recipients with late graftfailure. Eight consecutive single-lung retraosplantatlons were performed in patients with previous single-lung (n=7), or double-lung (n=l) transplant. Primary graft and native lung were removed in 5 and 3 patients, respectively. The delay between the two surgical procedures was 16±10 months (range 6-37 months). Three patients died within 3 months. Long-term survivors experienced stable and satisfactory functional results (forced expiratory volume in one second (FEV 1 63±21% predicted; range % predicted), with survival values ranging 8-20 months. One patient died of septic shock 16.5 months after retraosplantation. The remaining four patients are alive. These data suggest that the retraosplantation option could be considered in selected patients with late graft-failure. The rma1 decision for retransplantatioo, however, is largely influenced by the current shortage of donor lungs. Eur Respir J., 1993, 6, service de Pneumologi.e et R~animation et INSERM 0226, Hopital Beaujon. Clichy, France. +service d'anatomopathologie, Hopital Beaujon, Clichy, France. ++service de Chirurgie Thoracique, Hopital Beaujon, Clichy, France. Correspondence: M. Foumier Service de Pneurnologie et Reanimation HOpital Beaujon 100 boulevard du G n~ral Leclerc Clichy Cedex France. Keywords: Bronchiolitis obliterans lung retransplanllltion Received: November Accepted after revision April Current actuarial survival data for lung transplantation [I] average 60% and 55% at 1 and 2 yrs, respectively. During the last 3 yrs, the postoperative risk of mortality has decreased, particularly for the single-lung transplantation procedure. However, as the life expectancy of lung-transplanted patients continues to increase, the late development of progressive respiratory insufficiency has emerged as a major problem in a number of transplant recipients. The most prominent cause of graft failure seems to be the development of a diffuse bronchiolitis obliterans (BO) [2], which responds poorly - or is refractory - to augmented immunosuppression. In such cases of irreversible graft-failure in transplant recipients, the retransplantation (ReT) option may be discussed. Operative mortality associated with lung ReT is reported to be high: 52% for combined heart-lung ReT, and 42% for single-lung ReT. In addition, one year actuarial survival following ReT is 30% for combined heart-lung, and 33% for single-lung [1]. However, these results may depend on the circumstances and/or indications for retransplantation [3). For example, data provided KRmTr and KAYE [1] refer to graft replacement in the early operative period, as well as retransplantation for late graftfailure in long-tenn survivors. We therefore decided, 3 yrs ago, to evaluate the feasibility and the benefits of single-lung retransplantation in lung-transplant recipients with late graft-failure. This report describes our experience with the first eight consecutive patients who underwent a single-lung retransplantation between January 1989 and July Study group Patients and methods Between March 1988 and July 1992, 49 patients underwent primary lung transplantation (single-lung 41; double-lung 8) in our centre; 80% of transplantrecipients were suffering from end-stage obstructive pulmonary disease. The decision to evaluate the ReT option for selected long-tenn survivors with graft-failure was taken in January 1989, and eight transplant recipients have been retransplanted so far. This study group comprises five males and three females, with a mean age of 48±10 years (range yrs). Underlying respiratory diseases included panlobular emphysema (n=3), chronic obstructive pulmonary disease (n=2).
2 SINGLE-LUNG RETRANSPLANTATION 1203 destructive histiocytosis X (n=2), and chronic postembolic pulmonary hypertension (n=l). At the time of primary transplantation, all but one had an obstructive ventilatory pattern, and all were oxygen-dependent. One bad a tracheostomy and required mechanical ventilation support. The patients received a single-lung (n=7), or a double-lung (n=1) transplant without cardiopulmonary bypass support. with the exception of patient no. 7, who had a severe pulmonary hypertension (table 1). course of intravenously administered methylprednisolone (1 g day- 1 ). In cases of resistant rejection, thls treatment was combined with a 5 day course of ALG, and followed by an increase in oral corticotherapy. Follow-up procedure Routine surveillance included fibreoptic bronchoscopy, with samples for microbiological studies on days 7, 15 Table 1. - Clinical and functional characteristics prior to retransplantation Post-operative Pre-operative FEV 1 % pred Last FEY, First Pt % pred SLT+ Best Last no. 18 L L R R R+L L L L Delay to Type of Tracheostomy* retransplantation retransplantation months No 8 Ipsilateral No 31 Controlateral Yes 15 Ipsilateral Yes 9 Ipsilateral Yes 10 Ipsilateral No 37 Controlateral Yes 16 Controlateral Yes 6 Ipsilateral SLT+: single lung transplantation; R: right lung; L: for at least 15 days prior to retransplantation. FEV,: left lung. *: mechanical ventilation through tracheostomy forced expiratory volume in one second. Immunosuppressive regimen for primary transplantation The immunosuppressive regimen for all patients included a preoperative intravenous injection of methylprednisolone (500 mg), and azathioprine (2 mg kg- 1 ). Postoperatively, cyclosporin A was given intravenously, and adjusted to maintain an average final concentration of 300 ng ml ' as assessed by radio-immunoassay (RlA) determination of whole-blood levels. Steroids were withheld for 14 days (patients nos. 1-4), or 1 month (patients nos. 5-8), and were then given orally (prednisolone 0.5 mg kg 1 q.d.), and further tapered. Azathioprine was given intravenously (2.5 mg kg ' q.d.), immediately after the surgical procedure, and then orally (l.5 mg kg 1 q.d.). Rabbit antilymphocyte globulins (ALG; Merieux, Lyon, France) were given in the postoperative period, on the basis of a 14 day course (patients nos. 1-4), or a 3 day course (patients nos. 5-8). After the flrst month, patients were usually given cyclosporin according to whole-blood levels ( ng ml' 1 ), azathioprine (1.5 mg kg ' q.d.), and prednisolone (0-0.5 mg kg- 1 q.d.). All patients were given anti-cytomegalovirus (CMV) gammaglobulins, and patients nos. 5-8 were also given acyclovir during the first postoperative month, as a prophylactic treatment for herpes simplex virus (HSV) infection. Acute allograft lung rejection was treated by a 3 day and 30. Additional bronchoscopies with transbronchial biopsies and bronchoalveolar lavage were indicated in response to clinical or paraclinical abnormalities consistent with graft dysfunction. Chest radiography, spirometry, and arterial blood gas determination were usually performed every 3 months during the first year. Patients were requested to perform daily measurements of their peak expiratory flow rate (PEFR), and to signal any persistent fall in the PEFR rate. Results Early and late follow-up after primary transplantation Respiratory events occurring during the first 3 months following transplantation are listed in table 2. Each patient experienced at least one episode of documented viral infection; causative viruses were CMV (eight episodes), and HSV (two episodes). The diagnosis of CMV infection required either the rapid detection of CMV from bronchoalveolar lavage, plasma or biopsy samples by viral cultures; or a cytopathic effect in bronchoalveolar cells or biopsy samples. Bronchial complications associated with defective healing of the anasto-mosis were observed
3 1204 M. FOURNIER ET AL. Table 2. - Preoperative donor and recipient CMV serologies; postoperative bronchopulmonary events after primary transplantation and retransplantation Primary transplantation Retransplantation Respiratory events* Respiratory events* Preoperative CMV Preoperative CMV Pt serologies Rej Vir Sac serologies Rej Vir Bac no. Donor/Recipient Donor/Recipient I+ 2 +I I I I I I+ 8 -I *: respiratory events (Rej: rejection episodes; Vir: viral airway or pulmonary episodes; Bac: bacterial bronchitis or pneumonia) that occurred during the first 3 months following transplantation. CMV: cytomegalovirus. in three patients (nos. I, 2 and 4). They were responsible for poor lobar ventilation, whkh was suspected on fibrescopic examination, and confirmed by isotopic ventilation and perfusion scans. However, a progressive improvement of respiratory condition was documented in each patient, resulting in stable individual values of forced expiratory volume in one second (FEV ) 1 ranging 41-69% of predicted values (mean of the group 52% predicted) (table 1). Two distinct pathological events were found to play a major role in graft-failure. In two of the three patients with abnormal bronchial healing and irreversible central airways stenosis, severe pulmonary infections were further associated with graft-failure. In patient no. 1, moreover, the accidental rupture of a balloon filled with liposoluble contrast material resulted in a diffuse alveolar filling that did not clear, and was attributed to transplantation-associated impairment of the airway [4], or lymphatic clearance. In six patients, development of severe BO was suspected to be the major cause of graft-failure. Deterioration in respiratory condition paralleled the loss in FEV 1 and arterial oxygen tension (Pao ), 2 and a patchy or diffuse defect pattern on isotopic perfusion scans of the graft. In patient no. 5, development of respiratory insufficiency occurred after two successive episodes of CMV infection. In these five patients, respiratory function continued to decline despite enhanced and prolonged immunosuppression. In each patient, ReT was discussed when Pao 2 and FEV 1 values had returned to pretransplant values (table 1). Five of the eight patients had a tracheostomy, and required mechanical ventilation support at least during the night; all were oxygen-dependent. The delay between primary transplantation and ReT was 16±10 months (range 6-37 months). Retransplantation: surgical procedure, immunosuppressive regimen and follow-up Once the decision to retransplant had been taken, the immunosuppressive regimen was modified: prednisolone dosage was tapered to 0-15 mg kg- q.d., and cyclosporin dosage was also reduced to obtain whole-blood levels in the range of mg:rn!- 1 Graft volume, perfusion distribution on scintigraphic pattern, and proximal airway aspect on fibrescopic examination were considered when deciding whether to remove the graft or the native lung. Major graft retraction and central airway stenosis indicated graft removal, for fear of surgical difficulties and further local infections, respectively. In more balanced situations, the lung with the best perfusion was left in place. In either case, single-lung ReT was performed without cardiopulmonary bypass. In three of the five grafts that were removed, the predominant pathological finding was a diffuse BO (patients nos. 3-5) associated to focal aspects of acute rejection in patient no. 3. Main pathological changes observed in the two other grafts (patient Nos. 1 and 8) consisted of diffuse interstitial pneumonia and organizing pneumonia, respectively. The post-operative immunosuppressive regimen was the same as for the primary procedure. As shown in table 3, two patients (Nos. 1 and 7) died within one month of multiorgan failure, and another (patient No. 8) died 1.2 months after surgery of cerebral haemorrhage. Patients whose survival exceeded 3 months experienced respiratory events (table 2) superimposable to those observed after primary transplantation. At 3 months, as supported by individual values of FEV 1 and Pao 2 at rest (table 3), their respiratory condition was satisfactory. Patient No. 2 died 16.5 months after ReT of a septic shock complicating an agranulocytosis. The other patients are alive, with stable lung function.
4 SINGLE-LUNG RBTRANSPLANTATION 1205 Table 3. - Clinical and functional results of single-lung retransplantation 3 months value Pt Follow-up Cause of death Pao 2 Paco 2 FEY 1 Graft perfusion No. months kpa kpa % pred % total 0.5, died Multiorgan failure , died Septic shock agranulocytosis 3 20, alive , alive , alive , alive , died Multiorgan failure 8 1.2, died Cerebral haemorrhage Pao 2 : arterial oxygen tension; Paco 2 : arterial carbon dioxide tension; FEY 1 : forced expiratory volume in one second. Discussion Single-lung transplantation (SL T) has proved beneficial in patients with advanced fibrosis [5], or end-stage chronic obstructive pulmonary clisease [6]. Shorter waiting times and technical simplicity are in favour of the SLT procedure. Conversely, bronchial complications develop more frequently than in heart-lung transplantation. As in other series [2, 7, 8], however, the major cause of graft-failure was the development of bronchiolitis obliterans. The progressive appearance of respiratory insufficiency, otherwise unexplained, and the inefficacy of augmented immunosuppression were more suggestive of BO development than examination of transbronchial biopsies. Interestingly, changes in chest films that paralleled development of respiratory insufficiency varied from one case to another. They included a progressive restriction of graft volume, evoking a fibrotic process (all patients except no. 5), or a moderate distension (patient no. 5) suggesting a diffuse obstruction of peripheral airways. Indeed, graft from the latter patient presented with a pure form of BO, whilst other grafts displayed focal aspects of organizing pneumonia associated with BO. Similar differences in histological patterns of BO have been detailed previously by ABERNATlfY et al. [9], who suggested that pure forms of BO may be related to chronic rejection, whilst SO-associated organizing pneumonia may be due to other pathological processes, including infections. A major requisite before indicating ReT is the assessment of graft-failure irreversibility. In the case of SOassociated respiratory insufficiency, the immunosuppresion regimen is usually gradually augmented: the successive failures of methylprednisolone bolus and ALG or OKT3 courses in improving arterial blood gases and spirometric values are considered as good markers of BO irreversibility. We observed, however, focal but typical aspects of acute rejection on histological examination of the graft removed from patient no. 3. 1b.is observation may be related to the reduction of the immunosuppressive regimen, imposed during tbe pre-ret period. We speculated, indeed, that prednisolone and cyclosporin dosage reductions would limit infections and healing problems [10], and would lower the risk for nephrotoxicity (11] in the postoperative period, respectively. Whilst on the waiting-list for ReT, patients with reduced immunosuppression did not experience further decline in the respiratory function; more of them died before ReT could be performed. Among ReT-recipients, those who survived beyond 3 months experienced no more infections or rejection episodes than after primary transplantation. Conversely, early post-ret deaths were due to multiorgan failure. The question of whether the pre-ret immunosuppressive regimen should be modified, therefore, remains open; on the other hand, in the postoperative period the same immunosuppressive regimen as for primary transplantation seems to be appropriate, as suggested in a recent paper by Mn..i..ER and PATIERSON [3]. ln terms of competition with patients waiting for primary transplant, priority was given to the latter, provided that they were suffering from advanced fibrosis or pulmonary hypertension. However, such patients represent a minority among the candidates for lung transplantation in our centre. Single-lung ReT procedure may offer the choice of removing the graft or the native lung when a single-lung primary transplantation has been performed previously. In each case in the present study, graft-failure was responsible for the development of severe respiratory insufficiency; removal of the native lung was indicated either for severe graft retraction or major central airway stenosis. However, we paid particular attention to the comparative distribution of the perfusion in each lung; in balanced situations, the lung receiving more than 50% of the perfusion was left in place. Removal, or leaving in
5 1206 M. FOURNIER ET AL. situ, important quantities of allogenic material was not taken into consideration [12]. The immunological consequences of either option may be of importance, but experience regarding long-tenn follow-up is very limited and, to our knowledge, experimental data have not been reported. However, among the five patients with survival values ranging from 8-20 months, none was suspected of developing BO. One of these patients (No. 6) had undergone a controlateral ReT: serial chest films and isotopic perfusion scans displayed no change in primary graft patterns, suggesting that failure of the primary graft was irreversible. Five of the eight single-lung ReT recipients in the present study are long-tenn survivors, with satisfactory respiratory conditions. These data cautiously support the single-lung ReT option for lung transplant recipients with late graft failure. Considerable pressures arise from the patient, his/her family and the transplant group to offer a second transplant to the recipient developing a late graft-failure. However, we like others, are facing an increasing shortage of donor lungs, which is clearly the principal limitation for ReT procedure. References l. Kriett JM, Kaye MP. - The registry of the International Society for heart transplantation: seventh official report, Heart Transplant 1990; 4: Scott JP, Higenbottam TW, Clelland CA, Smyth RL, Stewart S, Wallwork J. - The natural history of chronic rejection in heart-lung transplant recipients: a clinical, pathological, and physiological review of 29 long-term survivors. Transplant Proc 1990; 22: Miller ID, Patterson GA. - Retransplantation following isolated lung transplantation. Semin Thorac Cardiovasc Surg 1992; 4(2): Read RC, Shankar S, Rutman A, et al. - Ciliary beat frequency and structure of recipient and donor epithelia following lung transplantation. Eur Respir ; 4: Toronto Lung Transplant Group. - Unilateral lung transplantation for pulmonary fibrosis. N Engl 1 Med 1986; 314: Mal H, Andreassian B, Pamela F, et al. - Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis 1989; 140: Paradis I, Dununer S, Dauber J. - Risk factors for the development of chronic rejection of the human allograft. Am Rev Respir Dis 1989; 139: A Tazelaar HD, Yousem SA. - The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol 1988; 19: Abemathy EC. Hruban RH, Baumgartoer WA, Reitz BA, Hutchins GH. - The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol 1991; 22: Lima 0, Cooper JD, Peters WJ, et al. - Effect of methylprednisolone and azathioprine on bronchial healing following lung autotransplantation. 1 Thorac Cardiovasc Surg 1981; 82: ll. Bennet WM, Nordman DJ. - Action and tolticity of cyclosporin. Annu Rev Med 1986; 37: Westra AL, Petersen AH, Prop J, Wildevuur CRH. - The combi-effect: reduced rejection of heart by combined transplantation with the lung or spleen. Transplantation 1991; 52:
The 1-year survival rate approaches 80% for patients
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Frank A. Pigula, MD, Bartley P. Griffith, MD, Marco A. Zenati, MD, James H. Dauber, MD, Samuel A. Yousem, MD, and Robert J.
More informationINTERNET-BASED HOME MONITORING OF PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION. 2000, 25 patients underwent heart lung (HLT) or bilateral-lung (BLT)
Online Supplement for: INTERNET-BASED HOME MONITORING OF PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION METHODS Patients Between the start of the study in June 1998 and the end of the study in September
More information1988 to January The original diagnoses are shown in table 1. Donor selection
Eur Respir J, 1995, 8, 5 9 DOI: 10.1183/09031936.95.08010005 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Pulmonary reimplantation response
More informationLung Allograft Dysfunction
Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to
More informationCitation for published version (APA): Ouwens, J. P. (2002). The Groningen lung transplant program: 10 years of experience Groningen: s.n.
University of Groningen The Groningen lung transplant program Ouwens, Jan Paul IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationProgression pattern of restrictive allograft syndrome after lung transplantation
http://www.jhltonline.org FEATURED ARTICLES Progression pattern of restrictive allograft syndrome after lung transplantation Masaaki Sato, MD, PhD, a,b David M. Hwang, MD, PhD, a Thomas K. Waddell, MD,
More informationEvolution of Surgical Therapies for End-Stage Cardiopulmonary Failure. Heart Failure at the Shoe XI October 5, 2012
Evolution of Surgical Therapies for End-Stage Cardiopulmonary Failure Heart Failure at the Shoe XI October 5, 2012 Robert S.D. Higgins, MD, MSHA Executive Director, Comprehensive Transplant Center Evolution
More informationRISK FACTORS FOR THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AFTER LUNG TRANSPLANTATION
Illllll RISK FACTORS FOR THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AFTER LUNG TRANSPLANTATION Timothy J. Kroshus, MD Vibhu R. Kshettry, MD Kay Savik, MS Ranjit John, MD Marshall I. Hertz, MD
More informationCitation for published version (APA): Ouwens, J. P. (2002). The Groningen lung transplant program: 10 years of experience Groningen: s.n.
University of Groningen The Groningen lung transplant program Ouwens, Jan Paul IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationPrevalence and Outcome of Bronchiolitis Obliterans Syndrome After Lung Transplantation
Prevalence and Outcome of Bronchiolitis Obliterans Syndrome After Lung Transplantation Sudhir Sundaresan, MD, Elbert P. Trulock, MD, Thallachallour Mohanakumar, PhD, Joel D. Cooper, MD, G. Alexander Patterson,
More informationPost Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ
Post Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ Art of Good Cooking Good Ingredient Good donor + OK recipient Good technique Good team Good timing Good
More informationLung transplantation has become a feasible option. Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation*
Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation* Jan W. K. van den Berg, MD, PhD; Petra J. van Enckevort, PhD; Elisabeth M. TenVergert, PhD; Dirkje S. Postma, MD, PhD; Wim
More informationE most common indication for bilateral lung transplantation.
Double-Lung Transplantation in Mechanically Ventilated Patients With Cystic Fibrosis Gilbert Massard, MD, Hani Shennib, MD, Dominique Metras, MD, Jean Camboulives, MD, Laurent Viard, MD, David S. Mulder,
More informationAnalysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
Cardiac and Pulmonary Replacement Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation Infection and rejection remain the greatest threats to the survival
More informationResults of single and bilateral lung transplantation in 131 consecutive recipients
Results of single and bilateral lung transplantation in 131 consecutive recipients We reviewed results of the first 131 recipients who received a single or bilateral sequential lung transplant at Barnes
More informationIdiopathic pulmonary fibrosis (IPF) is a major type. A New Treatment Strategy for Advanced Idiopathic Interstitial Pneumonia*
A New Treatment Strategy for Advanced Idiopathic Interstitial Pneumonia* Living-Donor Lobar Lung Transplantation Hiroshi Date, MD; Yasushi Tanimoto, MD; Keiji Goto, MD; Ichiro Yamadori, MD; Motoi Aoe,
More informationThirteen-Year Experience in Lung Transplantation for Emphysema
Thirteen-Year Experience in Lung Transplantation for Emphysema Stephen D. Cassivi, MD, Bryan F. Meyers, MD, Richard J. Battafarano, MD, Tracey J. Guthrie, RN, Elbert P. Trulock, MD, John P. Lynch, MD,
More informationPressure to expand the donor pool has affected all
Effect of Donor Age and Ischemic Time on Intermediate Survival and Morbidity After Lung Transplantation* Dan M. Meyer, MD; Leah E. Bennett, PhD; Richard J. Novick, MD; and Jeffrey D. Hosenpud, MD Background:
More informationM.S. Karetzky, R.R. Jasani, M.A. Zubair and Newark Beth Israel Medical Center Lung Transplant Group
Eur Respir J, 1996, 9, 2553 2559 DOI: 10.1183/09031936.96.09122553 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Thallium-201 scintigraphy
More informationSuccessful lung transplantation for adolescents at a hospital for adults
Successful lung transplantation for adolescents at a hospital for adults Judith M Morton, Monique A Malouf, Marshall L Plit, Phillip M Spratt and Allan R Glanville Lung transplantation (LTx) in adolescents
More informationExtracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure
Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all
More informationAcute Respiratory Distress Syndrome (ARDS) An Update
Acute Respiratory Distress Syndrome (ARDS) An Update Prof. A.S.M. Areef Ahsan FCPS(Medicine) MD(Critical Care Medicine) MD ( Chest) Head, Dept. of Critical Care Medicine BIRDEM General Hospital INTRODUCTION
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationCLINICAL SCIENCE. doi: /S
CLINICS 2009;64(6):519-25 CLINICAL SCIENCE Spirometric assessment of lung transplant patients: one year follow-up Paulo M. Pêgo-Fernandes, Fernando Conrado Abrão, Frederico Leon Arrabal Fernandes, Marlova
More informationReperfusion Injury Significantly Impacts Clinical Outcome After Pulmonary Transplantation
Reperfusion Injury Significantly Impacts Clinical Outcome After Pulmonary Transplantation Robert C. King, MD, Oliver A. R. Binns, MD, Filiberto Rodriguez, MD, R. Chai Kanithanon, BA, Thomas M. Daniel,
More information06/04/2013 ISHLT. 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013
LUNG TRANSPLANTS The Journal of Heart and Lung Transplantation, 2012 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013 LUNG TRANSPLANTATION:STATE OF THE ART L. Santambrogio
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationBronchiolitis obliterans syndrome (BOS) results in a
Ischemia-Reperfusion Injury After Lung Transplantation Increases Risk of Late Bronchiolitis Obliterans Syndrome Steven M. Fiser, MD, Curtis G. Tribble, MD, Stewart M. Long, MD, Aditya K. Kaza, MD, John
More informationThe Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale
The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant
More informationA CASE OF UNFORTUNATE
A CASE OF UNFORTUNATE TAPER Hélène Schoemans, MD University Hospitals Leuven, Belgium EBMT Complications and Quality of Life Working Party Educational Course Warsaw, October 24 th 2014 Company name No
More informationLiving lobar lung transplantation was introduced in 1993 in response. A decade of living lobar lung transplantation: Recipient outcomes GTS
A decade of living lobar lung transplantation: Recipient outcomes Vaughn A. Starnes, MD Michael E. Bowdish, MD Marlyn S. Woo, MD Richard G. Barbers, MD Felicia A. Schenkel, RN Monica V. Horn, RN Renzo
More informationCytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia
Cytomegalovirus (CMV) Viral Load in Bronchoalveolar Lavage Fluid (BALF) and Plasma to Diagnose Lung Transplant Associated CMV Pneumonia I.P. Lodding 1,2, H.H. Schultz 3, J.U. Jensen 1,5, C. Andersen 4,
More informationSingle-lung transplantation in the setting of aborted bilateral lung transplantation
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2011 Single-lung transplantation in the setting of aborted bilateral lung transplantation Varun Puri Tracey Guthrie
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: The National Heart, Lung, and Blood Institute Acute Respiratory
More informationSurgical treatment of bullous lung disease
Surgical treatment of bullous lung disease PD POTGIETER, SR BENATAR, RP HEWITSON, AD FERGUSON Thorax 1981 ;36:885-890 From the Respiratory Clinic, Groote Schuur Hospita', and Departments of Medicine, Anaesthetics,
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationWhat do pulmonary function tests tell you?
Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical
More informationEndothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients
Cardiothoracic Transplantation Salama et al Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients Mohamed Salama, MD, a,b Peter Jaksch, MD, a
More informationBILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
BILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE Joseph E. Bavaria, MD Robert Kotloff, MD Harold Palevsky, MD Bruce Rosengard, MD John R. Roberts, MD Peter M. Wahl,
More informationSubject Index. Bacterial infection, see Suppurative lung disease, Tuberculosis
Subject Index Abscess, virtual 107 Adenoidal hypertrophy, features 123 Airway bleeding, technique 49, 50 Airway stenosis, see Stenosis, airway Anaesthesia biopsy 47 complications 27, 28 flexible 23 26
More informationT evolved from en bloc heart-lung transplantation to en
Double-Lung Transplantation in Children: A Report of 20 Cases Dominique Mktras, MD, Hani Shennib, MD, Bernard Kreitmann, MD, Jean Camboulives, MD, Laurent Viard, MD, Michel Carcassonne, MD, Roger Giudicelli,
More informationAcute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations
Acute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations D. Novitzky, M.D., D. K. C. Cooper, Ph.D., F.R.C.S., A. G. Rose, Ch.B., M.Med.(Path),
More informationCitation for published version (APA): Ouwens, J. P. (2002). The Groningen lung transplant program: 10 years of experience Groningen: s.n.
University of Groningen The Groningen lung transplant program Ouwens, Jan Paul IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationSurvival impact of lung transplantation for COPD
Eur Respir J 2010; 36: 74 80 DOI: 10.1183/09031936.00087809 CopyrightßERS 2010 Survival impact of lung transplantation for COPD S. Lahzami*, P.O. Bridevaux #, P.M. Soccal #,", J. Wellinger +, J.H. Robert
More informationTREATMENT OF REFRACTORY ACUTE ALLOGRAFT REJECTION WITH AEROSOLIZED CYCLOSPORINE IN LUNG TRANSPLANT RECIPIENTS
TREATMENT OF REFRACTORY ACUTE ALLOGRAFT REJECTION WITH AEROSOLIZED CYCLOSPORINE IN LUNG TRANSPLANT RECIPIENTS Robert J. Keenan, MD Aldo Iacono, MD James H. Dauber, MD Adriana Zeevi, PhD Samuel A. Yousem,
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationFariba Rezaeetalab Associate Professor,Pulmonologist
Fariba Rezaeetalab Associate Professor,Pulmonologist rezaitalabf@mums.ac.ir Patient related risk factors Procedure related risk factors Preoperative risk assessment Risk reduction strategies Age Obesity
More informationHeart-lung transplantation for cystic fibrosis. 2: Outcome
1022 Archives ofdisease in Childhood 1991; 66: 1022-1026 The Hospital for Sick Children, London B Whitehead P Helms M Goodwin I Martin M Elliott M de Leval Papworth Hospital, Papworth Everard, Cambridge
More informationCell Therapy for Lung Indications Choosing the appropriate IND Enabling Animal Model
Cell Therapy for Lung Indications Choosing the appropriate IND Enabling Animal Model Marlowe Eldridge MD Department of Pediatrics and Biomedical Engineering University of Wisconsin School of Medicine and
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationACUTE RESPIRATORY DISTRESS SYNDROME
ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe
More informationI topic liver transplantation (OLT) to avoid organ
ORIGINAL ARTICLES Long-Term Immunosuppression Without Corticosteroids After Orthotopic Liver Transplantation: A Positive Therapeutic Aim Gerald M. Fraser, * Kons tantinos Grammous tianos, Jayendravandan
More informationLung Injury after HCT
Lung Injury after HCT J. Douglas Rizzo, MD, MS Financial Disclosure None SCS06_1.ppt Background HCT an important therapeutic modality for malignant and non-malignant diseases Pulmonary Toxicity common
More informationGeert M. Verleden, MD, PhD, FERS. Medical Director Leuven Lung Transplant Program
Geert M. Verleden, MD, PhD, FERS Medical Director Leuven Lung Transplant Program History of BOS A working formulation for the standardization of nomenclature and for clinical staging of Chronic C Dysfunction
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: heart_lung_transplantation 5/1985 6/2018 6/2019 6/2018 Description of Procedure or Service Combined heart/lung
More informationNew respiratory symptoms and lung imaging findings in a woman with polymyositis
Maria Bolaki 1, Konstantinos Karagiannis 1, George Bertsias 2, Ioanna Mitrouska 1, Nikolaos Tzanakis 1, Katerina M. Antoniou 1 kantoniou@uoc.gr 1 Dept of Thoracic Medicine, Heraklion University Hospital,
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationPeople with asthma who smoke. The combination of asthma, a chronic airway disease, and smoking increases the risk of COPD even more.
COPD Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, sputum (phlegm) production
More informationMODERATOR Felix Rapaport, other members of this
The First Lung Transplant in Man (1963) and the First Heart Transplant in Man (1964) J.D. Hardy MODERATOR Felix Rapaport, other members of this distinguished panel, and members of the audience, I will
More informationInduction Immunosuppression for Lung Transplantation With OKT3
Induction Immunosuppression for Lung Transplantation With OKT3 John C. Wain, MD, Cameron D. Wright, MD, Daniel P. Ryan, MD, Susan L. Zorb, RN, Douglas J. Mathisen, MD, and Leo C. Ginns, MD Thoracic Surgical,
More informationLong-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study
Eur Respir J, 1996, 9, 1246 1250 DOI: 10.1183/09031936.96.09061246 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Long-term nasal intermittent
More information4.6 Small airways disease
4.6 Small airways disease Author: Jean-Marc Fellrath 1. INTRODUCTION Small airways are defined as any non alveolated and noncartilaginous airway that has an internal diameter of 2 mm. Several observations
More informationUIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION!
UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION! STÉPHANE JOUNEAU 11 JULY 2014 Respiratory Medicine Department, Pontchaillou Hospital, Rennes, France CASE OVERVIEW This case highlights how a usual
More informationNHS. Living-donor lung transplantation for end-stage lung disease. National Institute for Health and Clinical Excellence. Issue date: May 2006
NHS National Institute for Health and Clinical Excellence Issue date: May 2006 Living-donor lung transplantation for end-stage Understanding NICE guidance information for people considering the procedure,
More informationCitation for published version (APA): Ouwens, J. P. (2002). The Groningen lung transplant program: 10 years of experience Groningen: s.n.
University of Groningen The Groningen lung transplant program Ouwens, Jan Paul IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationChapter 4 Section 24.1
Surgery Chapter 4 Section 24.1 Issue Date: October 27, 1995 Authority: 32 CFR 199.4(e)(5) 1.0 CPT 1 PROCEDURE CODES 32850-32854, 33930-33935 2.0 DIAGNOSTIC RELATED GROUPS (DRGs) 495 for lung transplant.
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationBilateral Versus Single Lung Transplant for Idiopathic Pulmonary Fibrosis
ArtIcle Bilateral Versus Single Lung Transplant for Idiopathic Pulmonary Fibrosis Sven Lehmann, 1* Madlen Uhlemann, 2* Sergey Leontyev, 1 Joerg Seeburger, 1 Jens Garbade, 1 Denis R. Merk, 1 Hartmuth B.
More informationVentilatory Mechanics in Patients with Cardio-Pulmonary Diseases. Part III. On Pulmonary Fibrosis
Ventilatory Mechanics in Patients with Cardio-Pulmonary Diseases Part III. On Pulmonary Fibrosis Kazuaki SERA, M.D. Pulmonary function studies have been undertaken on the pulmonary fibrosis as diagnosed
More informationFVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction
Original Research PSYCHOLOGICAL TESTING FVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction Judith Cohen, MD; Dirkje S. Postma, MD, PhD; Karin Vink-Klooster;
More informationCitation for published version (APA): Ouwens, J. P. (2002). The Groningen lung transplant program: 10 years of experience Groningen: s.n.
University of Groningen The Groningen lung transplant program Ouwens, Jan Paul IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationFollow up of Icelandic and Swedish Lung Transplant Patients
Follow up of Icelandic and Swedish Lung Transplant Patients in the years 2010 2012 Hjalti Ásgeirsson Supervisors: Chief Supervisor Gerdt Riise; Co-supervisors Gunnar Guðmundsson, Helga Ásgeirsdóttir, Hrönn
More informationRespiratory Pathology. Kristine Krafts, M.D.
Respiratory Pathology Kristine Krafts, M.D. Normal lung: alveolar spaces Respiratory Pathology Outline Acute respiratory distress syndrome Obstructive lung diseases Restrictive lung diseases Vascular
More informationRespiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician
Respiratory Disease Dr Amal Damrah consultant Neonatologist and Paediatrician Signs and Symptoms of Respiratory Diseases Cardinal Symptoms Cough Sputum Hemoptysis Dyspnea Wheezes Chest pain Signs and Symptoms
More informationPreoperative assessment for lung resection. RA Dyer
Preoperative assessment for lung resection RA Dyer 2016 The ideal assessment of operative risk would identify every patient who could safely tolerate surgery. This ideal is probably unattainable... Mittman,
More informationMISDIAGNOSED MALIGNANCY IN TRANSPLANTED ORGANS.
MISDIAGNOSED MALIGNANCY IN TRANSPLANTED ORGANS. O. Detry, B. Detroz, M. D'Silva, J.O. Defraigne, M.Meurisse, P.Honore, R. Limet, N. Jacquet. Department of Surgery and Transplantation. CHU Sart-Tilman,
More informationAppendix E1. Epidemiology
Appendix E1 Epidemiology Viruses are the most frequent cause of human infectious diseases and are responsible for a spectrum of illnesses ranging from trivial colds to fatal immunoimpairment caused by
More informationINDEPENDENT LUNG VENTILATION
INDEPENDENT LUNG VENTILATION Giuseppe A. Marraro, MD Director Anaesthesia and Intensive Care Department Paediatric Intensive Care Unit Fatebenefratelli and Ophthalmiatric Hospital Milan, Italy gmarraro@picu.it
More informationDoes ambroxol confer a protective effect on the lungs in patients undergoing cardiac surgery or having lung resection?
Interactive CardioVascular and Thoracic Surgery 18 (2014) 830 834 doi:10.1093/icvts/ivu061 Advance Access publication 12 March 2014 BEST EVIDENCE TOPIC THORACIC Does ambroxol confer a protective effect
More informationNo evidence of C4d association with AMR However, C3d and AMR correlated well
C4d positivity Poor prognostic factor Reversal to C4d negativity did not change prognosis, with current therapy Prognostic factor for CAV Variable time line for CAV/death No correlation with cellular rejection
More informationJune 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2
June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic
More informationH tients with end-stage pulmonary hypertension was
Pediatric Lung Transplantation for Pulmonary Hypertension and Congenital Heart Disease Thomas L. Spray, MD, George B. Mallory, MD, Charles E. Canter, MD, Charles B. Huddleston, MD, and Larry R. Kaiser,
More informationDéjà vu all over again
Disclosures Déjà vu all over again None Jonathan Singer MD MS University of California, San Francisco HPI 49 y/o woman presents for lung transplant evaluation for Hypersensitivity Pneumonitis Exposures:
More informationPulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation
LUNG TRANSPLANTATION Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation Laura S Mackay, Rachel L Anderson, Gareth Parry, James Lordan, Paul A Corris, Andrew
More informationOntario s Referral and Listing Criteria for Adult Lung Transplantation
Ontario s Referral and Listing Criteria for Adult Lung Transplantation Version 3.0 Trillium Gift of Life Network Adult Lung Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient
More informationHeart/Lung Transplant. Populations Interventions Comparators Outcomes Individuals: With end-stage cardiac and pulmonary disease.
Protocol Heart/Lung Transplant (70308) Medical Benefit Effective Date: 04/01/14 Next Review Date: 01/19 Preauthorization Yes Review Dates: 01/10, 01/11, 01/12, 01/13, 01/14, 01/15, 01/16, 01/17, 01/18
More informationOxygenation. Chapter 45. Re'eda Almashagba 1
Oxygenation Chapter 45 Re'eda Almashagba 1 Respiratory Physiology Structure and function Breathing: inspiration, expiration Lung volumes and capacities Pulmonary circulation Respiratory gas exchange: oxygen,
More information#8 - Respiratory System
Page1 #8 - Objectives: Study the parts of the respiratory system Observe slides of the lung and trachea Equipment: Remember to bring photographic atlas. Figure 1. Structures of the respiratory system.
More informationLung Transplantation. Introduction. Current Status
Page 1 of 24 To Print: Click your browser's PRINT button. NOTE: To view the article with Web enhancements, go to: http://www.medscape.com/viewarticle/436545 Lung Transplantation This activity is made possible
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More informationGastroesophageal Reflux Disease Is Associated With an Increased Rate of Acute Rejection in Lung Transplant Allografts
Gastroesophageal Reflux Disease Is Associated With an Increased Rate of Acute Rejection in Lung Transplant Allografts Kenneth Leeper Jr., Emory University N.S. Shah, Emory University Seth Force, Emory
More informationMai ElMallah,MD Updates in Pediatric Pulmonary Care XII: An Interdisciplinary Program April 13, 2012
Mai ElMallah,MD Updates in Pediatric Pulmonary Care XII: An Interdisciplinary Program April 13, 2012 Recognize the importance of Pulmonary Function Testing in Cystic Fibrosis Be aware of different types
More informationAspergillus INFECTION IN SINGLE AND DOUBLE LUNG TRANSPLANT RECIPIENTS
March 27, 1996 WESTNEY ET AL. 915 17. Duncan J, Radovancevic B, Frazier O. Ventricular assist devices. Cardiac Surgery: state of the art reviews. 1990; 4: 321. 18. Radovancevic B, Biroluljew S, Frazier
More informationAdvanced Medicine 2016 Lung Transplantation. Paul A Corris Newcastle University Newcastle Upon Tyne UK
Advanced Medicine 2016 Lung Transplantation Paul A Corris Newcastle University Newcastle Upon Tyne UK First Human Lung Transplantation 1963 JAMA 1963;186:1065-74 The lung donor was a NHBD who died from
More informationCHAPTER 3 SECTION 1.6B HEART-LUNG AND LUNG TRANSPLANTATION TRICARE POLICY MANUAL M, MARCH 15, 2002 SURGERY AND RELATED SERVICES
TRICARE POLICY MANUAL 6010.47-M, MARCH 15, 2002 SURGERY AND RELATED SERVICES CHAPTER 3 SECTION 1.6B ISSUE DATE: October 27, 1995 AUTHORITY: 32 CFR 199.4(e)(5) I. CODES A. CPT 1 Procedure Codes 33930, 33935,
More informationLung Transplantation in Infants and Toddlers from 1990 to 2004 at St. Louis Children s Hospital
American Journal of Transplantation 2009; 9: 719 726 Wiley Periodicals Inc. C 2009 The Authors Journal compilation C 2009 The American Society of Transplantation and the American Society of Transplant
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: lung_volume_reduction_surgery 4/1996 3/2018 3/2019 3/2018 Description of Procedure or Service Emphysema is
More informationDoes the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,
More informationMethods ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE
ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE Li-Hui Soh, Chih-Feng Chian, Wen-Lin Su, Horng-Chin Yan, Wann-Cherng Perng, and Chin-Pyng Wu Background
More informationBronchoalveolar lavage (BAL) with surfactant in pediatric ARDS
Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS M. Luchetti, E. M. Galassini, A. Galbiati, C. Pagani,, F. Silla and G. A. Marraro gmarraro@picu.it www.picu.it Anesthesia and Intensive Care
More information